We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M Turnover 66.25%
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
-3.93%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$58.4M
AUM Growth
-$35.8M
Cap. Flow
-$13.1M
Cap. Flow %
-22.36%
Top 10 Hldgs %
41.11%
Holding
109
New
27
Increased
13
Reduced
25
Closed
40
Avg Time Held Equity + Options
0.8 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.8 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$2.5M
2
NXPI icon
NXP Semiconductors
NXPI
+$2.09M
3
WDC icon
Western Digital
WDC
+$1.49M
4
CI icon
Cigna
CI
+$1.16M
5
NVS icon
Novartis
NVS
+$962K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.44M
2
HUM icon
Humana
HUM
+$2.73M
3
BABA icon
Alibaba
BABA
+$2.34M
4
DIS icon
Walt Disney
DIS
+$1.74M
5
PYPL icon
PayPal
PYPL
+$1.72M

Sector Composition

Rank Sector Weight
1 Healthcare 53.01%
2 Technology 26.41%
3 Miscellaneous 14.9%
4 Financials 2.04%
5 Communication Services 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ZBH icon
1
Zimmer Biomet
ZBH
$18.1B
$2.43M 4.16%
18,219
-3,832
-17% -$495K
2017 Q4
7 quarters
NXPI icon
2
NXP Semiconductors
NXPI
$58.6B
$2.23M 3.83%
+20,473
New +$2.09M
2019 Q3
0 quarters
MCHP icon
3
Microchip Technology
MCHP
$40.6B
$2.23M 3.82%
47,992
+3,280
+7% +$149K
2018 Q4
3 quarters
ALXN
4
DELISTED
Alexion Pharmaceuticals
ALXN
$2.17M 3.71%
+22,136
New +$2.5M
2019 Q3
0 quarters
BMRN icon
5
BioMarin Pharmaceuticals
BMRN
$10.6B
$1.98M 3.39%
29,341
+3,731
+15% +$287K
2019 Q2
1 quarter
GILD icon
6
Gilead Sciences
GILD
$194B
$1.81M 3.09%
28,502
+7,400
+35% +$484K
2019 Q2
1 quarter
TWLO icon
7
Twilio
TWLO
$36.9B
$1.74M 2.97%
15,783
+7,139
+83% +$926K
2018 Q4
3 quarters
PEN icon
8
Penumbra
PEN
$12.6B
$1.69M 2.89%
12,558
+3,898
+45% +$603K
2016 Q3
12 quarters
WDC icon
9
Western Digital
WDC
$128B
$1.57M 2.69%
+34,829
New +$1.49M
2019 Q3
0 quarters
INTU icon
10
Intuit
INTU
$86.3B
$1.52M 2.61%
5,722
-441
-7% -$121K
2018 Q1
6 quarters
CRM icon
11
Salesforce
CRM
$198B
$1.49M 2.55%
10,032
-7,020
-41% -$1.07M
2017 Q2
9 quarters
GDDY icon
12
GoDaddy
GDDY
$13.4B
$1.45M 2.48%
21,910
-1,475
-6% -$100K
2016 Q4
11 quarters
ARNA
13
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.32M 2.26%
28,877
+10,718
+59% +$602K
2018 Q2
5 quarters
IQV icon
14
IQVIA
IQV
$43.7B
$1.28M 2.19%
8,567
-975
-10% -$152K
2019 Q1
2 quarters
XBI icon
15
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.57B
$1.25M 2.14%
+16,400
New +$1.36M
2019 Q3
0 quarters
AGN
16
DELISTED
Allergan plc
AGN
$1.24M 2.12%
7,374
-21,143
-74% -$3.44M
2019 Q1
2 quarters
WCG
17
DELISTED
Wellcare Health Plans, Inc.
WCG
$1.23M 2.11%
4,757
-2,442
-34% -$674K
2019 Q1
2 quarters
ALNA
18
DELISTED
Allena Pharmaceuticals
ALNA
$1.12M 1.92%
284,285
-3,566
-1% -$15.3K
2017 Q4
7 quarters
CI icon
19
Cigna
CI
$79.4B
$1.08M 1.85%
+7,132
New +$1.16M
2019 Q3
0 quarters
MSFT icon
20
Microsoft
MSFT
$3.92T
$1.03M 1.76%
7,383
-3,092
-30% -$425K
2018 Q3
4 quarters
IRTC icon
21
iRhythm Holdings
IRTC
$3.65B
$946K 1.62%
12,761
+5,089
+66% +$394K
2018 Q2
5 quarters
NVS icon
22
Novartis
NVS
$287B
$927K 1.59%
+10,711
New +$962K
2019 Q3
0 quarters
HCA icon
23
HCA Healthcare
HCA
$99.5B
$903K 1.55%
7,500
-4,060
-35% -$525K
2017 Q4
7 quarters
EW icon
24
Edwards Lifesciences
EW
$49.8B
$818K 1.4%
11,157
-11,691
-51% -$821K
2014 Q4
19 quarters
SYK icon
25
Stryker
SYK
$113B
$806K 1.38%
3,728
-4,139
-53% -$888K
2019 Q1
2 quarters
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, Partner Investment Management held 109 positions worth $58.4M, down 38% from $94.2M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Partner Investment Management withdrew a net $13.1M in Q3 2019, closing 40 positions and reducing 25 holdings. Its most notable exit was Humana, an estimated $2.73M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 46% a quarter earlier, followed by Technology and Miscellaneous.

Against the trend, Partner Investment Management opened a new position in Alexion Pharmaceuticals worth $2.17M.

  • Partner Investment Management's largest Q3 2019 buy was Alexion Pharmaceuticals: 22,136 shares worth $2.17M.
  • Partner Investment Management added most to Twilio in Q3 2019, an estimated $926K increase.
  • Partner Investment Management's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $3.44M.
  • Partner Investment Management fully exited Humana in Q3 2019, selling an estimated $2.73M.
  • Partner Investment Management's ten largest holdings make up 41% of its $58.4M portfolio in Q3 2019.
  • Partner Investment Management opened 27 new positions and closed 40 in Q3 2019.
  • Partner Investment Management's portfolio value fell 38% quarter-over-quarter to $58.4M.

Based on Partner Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.